AAAAAA
Results:
1-9
|
Results: 9
Authors:
Lofland, JH
Locklear, JC
Frick, KD
Citation: Jh. Lofland et al., Different approaches to valuing the lost productivity of patients with migraine, PHARMACOECO, 19(9), 2001, pp. 917-925
Authors:
Maio, V
Girts, TK
Lofland, JH
Nash, DB
Citation: V. Maio et al., Pharmacoeconomic fellowships - The need for outcome measures, PHARMACOECO, 19(8), 2001, pp. 795-802
Authors:
Lofland, JH
Szarlej, D
Buttaro, T
Shermock, S
Jalali, S
Citation: Jh. Lofland et al., Untitled, CLIN J PAIN, 17(1), 2001, pp. 103-104
Authors:
Lofland, JH
Kim, SS
Batenhorst, AS
Johnson, NE
Chatterton, ML
Cady, RK
Kaniecki, R
Nash, DB
Citation: Jh. Lofland et al., Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine, MAYO CLIN P, 76(11), 2001, pp. 1093-1101
Authors:
Meletiche, DM
Lofland, JH
Young, WB
Citation: Dm. Meletiche et al., Quality-of-life differences between patients with episodic and transformedmigraine, HEADACHE, 41(6), 2001, pp. 573-578
Authors:
Lofland, JH
Schaffer, M
Goldfarb, N
Citation: Jh. Lofland et al., Evaluating health-related quality of life: Cost comparison of computerizedtouch-screen technology and traditional paper systems, PHARMACOTHE, 20(11), 2000, pp. 1390-1395
Authors:
Meletiche, DM
Doshi, D
Lofland, JH
Citation: Dm. Meletiche et al., Medical outcomes study short form 36: A possible source of utilities?, CLIN THER, 21(11), 1999, pp. 2016-2026
Authors:
Lofland, JH
Johnson, NE
Batenhorst, AS
Nash, DB
Citation: Jh. Lofland et al., Changes in resource use and outcomes for patients with migraine treated with sumatriptan - A managed care perspective, ARCH IN MED, 159(8), 1999, pp. 857-863
Authors:
Lofland, JH
Johnson, NE
Batenhorst, AS
Nash, DB
Citation: Jh. Lofland et al., Changes in resource use and outcomes for patients with migraine treated with sumatriptan (vol 159, pg 857, 1999), ARCH IN MED, 159(18), 1999, pp. 2228-2228
Risultati:
1-9
|